These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10571617)

  • 21. [Pharmacological treatment of urinary incontinence and difficulty in emptying the bladder in women].
    Thind P; Lose G
    Ugeskr Laeger; 1985 Dec; 147(49):3989-92. PubMed ID: 2868553
    [No Abstract]   [Full Text] [Related]  

  • 22. [Medical treatment of voiding problems in men].
    Andersen JT; Nordling J; Walter S
    Ugeskr Laeger; 2007 May; 169(20):1892-4. PubMed ID: 17553364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medical treatment of disorders of the bladder sphincter].
    Dagues F; Costa P
    Rev Prat; 1995 Feb; 45(3):337-41. PubMed ID: 7725039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients.
    Zinner NR; Mattiasson A; Stanton SL
    J Am Geriatr Soc; 2002 May; 50(5):799-807. PubMed ID: 12028164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of urinary incontinence in older persons.
    Zarowitz BJ; Ouslander JG
    Geriatr Nurs; 2006; 27(5):265-70. PubMed ID: 17045125
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of daytime urinary incontinence: A standardization document from the International Children's Continence Society.
    Chang SJ; Van Laecke E; Bauer SB; von Gontard A; Bagli D; Bower WF; Renson C; Kawauchi A; Yang SS
    Neurourol Urodyn; 2017 Jan; 36(1):43-50. PubMed ID: 26473630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing urinary incontinence in women - a review of new and emerging pharmacotherapy.
    Bientinesi R; Sacco E
    Expert Opin Pharmacother; 2018 Dec; 19(18):1989-1997. PubMed ID: 30304645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug therapy in urinary incontinence and/or bladder emptying problems].
    Møller LA; Abel I; Thyssen H; Sander P; Mouritsen L; Lose G; Sørensen C; Philipsen J; Ottesen M; Rasmussen FA; Topp M; Larsen J; Gimbel H
    Ugeskr Laeger; 2006 Jun; 168(26-32):2580-1; author reply 2581. PubMed ID: 16824423
    [No Abstract]   [Full Text] [Related]  

  • 29. Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder.
    Jacquetin B; Wyndaele J
    Eur J Obstet Gynecol Reprod Biol; 2001 Sep; 98(1):97-102. PubMed ID: 11516807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic strategy and impact of new treatments].
    Haab F
    Ann Urol (Paris); 2005 Dec; 39 Suppl 6():S188-91. PubMed ID: 16440495
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations.
    Hashim H; Abrams P
    Drugs; 2004; 64(15):1643-56. PubMed ID: 15257626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anticholinergic treatment of overactive bladder. A costly treatment with doubtful clinical effect?].
    Møller LA; Lose G
    Ugeskr Laeger; 2003 Nov; 165(47):4552-3. PubMed ID: 14677238
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug therapy of urinary incontinence].
    Schütz W
    Med Klin; 1980 Feb; 75(3):127-31. PubMed ID: 6103504
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of men with lower urinary tract symptoms and overactive bladder.
    Bell WA; Amarshi N
    JAMA; 2007 Mar; 297(11):1192; author reply 1193. PubMed ID: 17374810
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diabetogenic bladder function diseases. Treatment in open studies with muscarinic receptor antagonists].
    Musch A
    Med Monatsschr Pharm; 2005 Sep; 28(9):329-30. PubMed ID: 16163888
    [No Abstract]   [Full Text] [Related]  

  • 36. Overactive bladder pharmacotherapy: what does the future hold?
    Dmochowski RR
    BJU Int; 2007 Jun; 99 Suppl 3():13-6. PubMed ID: 17488368
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug treatment options in urinary incontinence.
    Wells M
    Community Nurse; 2000 Feb; 6(1):11-2. PubMed ID: 11144190
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of overactive bladder.
    Ouslander JG
    N Engl J Med; 2004 Feb; 350(8):786-99. PubMed ID: 14973214
    [No Abstract]   [Full Text] [Related]  

  • 39. [Overactive bladder--treatment with antimuscarinic agents].
    Höfner K
    Urologe A; 2003 Jun; 42(6):793-800. PubMed ID: 12851770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimuscarinic drugs.
    McLoughlin C
    Prof Nurse; 2004 Sep; 20(1):50-1. PubMed ID: 15468784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.